A detailed history of Stonebridge Financial Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Stonebridge Financial Group, LLC holds 998 shares of LLY stock, worth $1.02 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
998
Previous 978 2.04%
Holding current value
$1.02 Million
Previous $762 Million 0.12%
% of portfolio
0.07%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

BUY
$625.65 - $812.69 $12,513 - $16,253
20 Added 2.04%
998 $761 Million
Q2 2025

Jul 24, 2025

BUY
$713.71 - $898.95 $4,995 - $6,292
7 Added 0.72%
978 $762 Million
Q1 2025

Apr 25, 2025

SELL
$725.72 - $929.72 $70,394 - $90,182
-97 Reduced 9.08%
971 $802 Million
Q4 2024

Jan 29, 2025

BUY
$727.2 - $932.06 $776,649 - $995,440
1,068 New
1,068 $824 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Stonebridge Financial Group, LLC Portfolio

Follow Stonebridge Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Financial Group, LLC with notifications on news.